NCT01599702View on ClinicalTrials.gov

Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Inflammatory Bowel Disease

Interventions

DRUG

Iron Isomaltoside 1000

1500-3000mg IV depending on HB level, sex and body weight

Trial Locations (1)

Unknown

Pharmacosmos A/S, Hoelbaek

Sponsors

Lead Sponsor

Pharmacosmos A/S

All Listed Sponsors

lead

Pharmacosmos A/S

INDUSTRY